Terms: = Endocrine gland cancer AND CARS, P49589, 833, ENSG00000110619
203 results:
1. Chimeric Antigen Receptor T Cell Therapy for Pancreatic cancer: A Review of Current Evidence.
Czaplicka A; Lachota M; Pączek L; Zagożdżon R; Kaleta B
Cells; 2024 Jan; 13(1):. PubMed ID: 38201305
[TBL] [Abstract] [Full Text] [Related]
2. Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions.
Sajman J; Yakovian O; Unger Deshet N; Almog S; Horn G; Waks T; Globerson Levin A; Sherman E
Cells; 2023 Sep; 12(18):. PubMed ID: 37759484
[TBL] [Abstract] [Full Text] [Related]
3. No relevant spectator impact on home advantage in male and female professional volleyball - A longitudinal multilevel logistic model analysis over 25 years.
van Meurs E; Rehr JP; Raue-Behlau C; Strauss B
Psychol Sport Exerc; 2023 May; 66():102401. PubMed ID: 37665863
[TBL] [Abstract] [Full Text] [Related]
4. The diagnostic value of ultrasound on different-sized thyroid nodules based on ACR TI-RADS.
Li W; Chen J; Ye F; Xu D; Fan X; Yang C
Endocrine; 2023 Dec; 82(3):569-579. PubMed ID: 37656349
[TBL] [Abstract] [Full Text] [Related]
5. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.
Deza S; Maroto J; Tellechea O; Orbegozo N; Merino J; Galofré JC; Alegre E; González Á
Clin Chim Acta; 2023 Aug; 548():117502. PubMed ID: 37516333
[TBL] [Abstract] [Full Text] [Related]
6. Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients.
Nakamura T; Okada KI; Ohtsuka M; Higuchi R; Takahashi H; Nagai K; Unno M; Murakami Y; Oba A; Tomikawa M; Kato A; Horiguchi A; Nakamura M; Yagi S; Satoi S; Endo I; Amano R; Matsumoto I; Ito YM; Nagakawa T; Hirano S
Br J Surg; 2023 Sep; 110(10):1387-1394. PubMed ID: 37469172
[TBL] [Abstract] [Full Text] [Related]
7. Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Brugel M; Marulier T; Evrard C; Carlier C; Tougeron D; Piessen G; Truant S; Turpin A; Williet N; Botsen D; Brasseur M; Perrier M; Bouché O
Pancreatology; 2023 Sep; 23(6):622-629. PubMed ID: 37394294
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
[TBL] [Abstract] [Full Text] [Related]
9. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model.
Ranoa DRE; Sharma P; Schane CP; Lewis AN; Valdez E; Marada VVVR; Hager MV; Montgomery W; Wolf SP; Schreiber K; Schreiber H; Bailey K; Fan TM; Hergenrother PJ; Roy EJ; Kranz DM
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258040
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial.
Holloway RW; Mendivil AA; Kendrick JE; Abaid LN; Brown JV; LeBlanc J; McKenzie ND; Mori KM; Ahmad S
JAMA Oncol; 2023 Jul; 9(7):903-908. PubMed ID: 37227734
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study.
Leng C; Cui Y; Mai Z; Chen R; Yuan J; Wang K; Wen J; Fu J; Liu Q
Int J Surg; 2023 Sep; 109(9):2574-2584. PubMed ID: 37222675
[TBL] [Abstract] [Full Text] [Related]
12. Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas.
Zhang Y; Li L; Ma X; Liu C; Liu G; Bie Z; Yang Z; Liu P
Front Endocrinol (Lausanne); 2023; 14():1137648. PubMed ID: 36936141
[TBL] [Abstract] [Full Text] [Related]
13. Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma.
Hong S; Lin B; Xu M; Zhang Q; Huo Z; Su M; Ma C; Liang J; Yu S; He Q; Su Z; Li Y; Liu R; Guo Z; Lv W; Xiao H
EBioMedicine; 2023 Apr; 90():104497. PubMed ID: 36868052
[TBL] [Abstract] [Full Text] [Related]
14. Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M; Giommoni E; Bergamo F; Milella M; Cavanna L; Di Marco MC; Spada M; Cordio S; Aprile G; Cardellino GG; Maiello E; Bernardini I; Ghidini M; Bozzarelli S; Macchini M; Orsi G; De Simone I; Rulli E; Porcu L; Torri V; Pinto C;
ESMO Open; 2023 Feb; 8(1):100777. PubMed ID: 36731325
[TBL] [Abstract] [Full Text] [Related]
15. Conventional ultrasonography and elastosonography in diagnosis of malignant thyroid nodules: A systematic review and meta-analysis.
Zhang D; Wang XN; Jiang L; Yu CX; Chen YN; Yu XJ; Pan MF
Front Endocrinol (Lausanne); 2022; 13():1082881. PubMed ID: 36686488
[TBL] [Abstract] [Full Text] [Related]
16. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract] [Full Text] [Related]
17. Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma.
McKenna MK; Ozcan A; Brenner D; Watanabe N; Legendre M; Thomas DG; Ashwood C; Cummings RD; Bonifant C; Markovitz DM; Brenner MK
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36653070
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative US Integrated Random Forest Model for Predicting Delphian Lymph Node Metastasis in Patients with Papillary Thyroid cancer.
Zhou C; Xu C; Yang B; Zhu Z; Huang Y; Shen B; Dong X; Xu X; Liu G
Curr Med Imaging; 2023; 19(9):1031-1040. PubMed ID: 36606588
[TBL] [Abstract] [Full Text] [Related]
19. [Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
Luo ZY; Qin JW; Fang JG; Zheng C; Gong WB; Hei H
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3856-3861. PubMed ID: 36540923
[No Abstract] [Full Text] [Related]
20. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
Wong KK; Bateman NW; Ng CW; Tsang YTM; Sun CS; Celestino J; Nguyen TV; Malpica A; Hillman RT; Zhang J; Futreal PA; Rojas C; Conrads KA; Hood BL; Dalgard CL; Wilkerson MD; Phippen NT; Conrads TP; Maxwell GL; Sood AK; Gershenson DM
J Transl Med; 2022 Dec; 20(1):606. PubMed ID: 36528667
[TBL] [Abstract] [Full Text] [Related]
[Next]
